ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0011

Clock Gene Bmal1 Promotes Transcriptional Activity of NF-κB to Regulate Production of Inflammatory Mediators in RA-FLS

Hikari Tsukamoto1, Kenta Kaneshiro2, Kohsuke Yoshida1, Koji Tateishi3, Yasuhiro Terashima3, Nao Shibanuma4, Yoshitada Sakai5 and Akira Hashiramoto1, 1Kobe University Graduate School of Health Sciences, Kobe, Japan, 2Kobe University Graduate School of Health Sciences, Osaka, Japan, 3Kohnan Kakogawa Hospital, Kakogawa, Japan, 4Kobe Kaisei Hospital, Kobe, Japan, 5Kobe University Graduate School of Medicine, Kobe, Japan

Meeting: ACR Convergence 2023

Keywords: Cell-signalling molecules, chemokines, Gene Expression, Morning Stiffness, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0009–0012) Cytokines & Cell Trafficking Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA), an autoimmune polyarthritis characterized by ‘tumor-like’ proliferation of RA fibroblast-like synovial cells (RA-FLS), has characteristic symptoms such as “morning stiffness of joints” related to circadian rhythms. Furthermore, the concentrations of inflammatory cytokines such as TNF-α, IL-6, and IFN-γ in sera of RA patients is also known to peak at midnight, prior to arthritic symptoms in the morning. Circadian rhythms in individual cells are regulated by the expressions of clock genes (Bmal1, Clock, Per, and Cry). We previously reported that TNF-α increased the expression of Bmal1 in RA-FLS which induced osteochondral destruction via production of inflammatory mediators. It has been reported that BMAL1 binds to NF-κB/p65 in breast cancer cells, leading to promotes MMP-9 transcription (Wang et al. Cancer Cell Int, 2019, 19:182), however, it remains unclear how Bmal1 is involved in the pathogenesis of RA. In this study, we examined the function and the mechanism that Bmal1 contributed the productions of inflammatory mediators in RA-FLS under cytokine stimulations.

Methods: After transfected Bmal1/siRNA, RA-FLSs were stimulated with or without TNF-α (20 ng/ml), IL-1β (20 ng/ml) or IFN-γ (20 ng/ml) for 32 hours to examine the expressions of inflammatory mediators; CCL2, IL-6, MMP-3 by qPCR. Next, we investigated NF-κB/p65 activity and an interaction between BMAL1 and NF-κB/p65 by immunofluorescence and co-immunoprecipitation. Total protein was extracted from RA-FLS to analyze the expression of phospho-p65/total p65 by western blotting.

Results: Under stimulation of TNF-α and IL-1β, the mRNA expression of CCL2 were significantly suppressed by silencing Bmal1. Similarly, under stimulation of IL-1β and IFN-γ, silencing Bmal1 suppressed the mRNA expressions of IL-6 and MMP-3, respectively (Fig 1). Under fluorescence observations, NF-κB/p65 translocated into the nucleus following TNF-α and IL-1β stimulation though it appeared to be suppressed by silencing Bmal1. Stimulation with IFN-γ had no effect on p65 (Fig 2). Furthermore, BMAL1 was combined with p65 (Fig 3-a), and a phosphorylation of p65 was suppressed by silencing Bmal1 under stimulations with TNF-α (Fig 3-b).

Conclusion: The results indicated Bmal1 promoted the phosphorylation and nuclear translocation of p65 via forming the complex, subsequently contributing to the production of inflammatory mediators in RA-FLS, which might consequently induce osteochondral destruction in RA.

Supporting image 1

Fig 1

Supporting image 2

Fig 2

Supporting image 3

Fig 3


Disclosures: H. Tsukamoto: None; K. Kaneshiro: None; K. Yoshida: None; K. Tateishi: None; Y. Terashima: None; N. Shibanuma: None; Y. Sakai: None; A. Hashiramoto: Eli Lilly, 5.

To cite this abstract in AMA style:

Tsukamoto H, Kaneshiro K, Yoshida K, Tateishi K, Terashima Y, Shibanuma N, Sakai Y, Hashiramoto A. Clock Gene Bmal1 Promotes Transcriptional Activity of NF-κB to Regulate Production of Inflammatory Mediators in RA-FLS [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/clock-gene-bmal1-promotes-transcriptional-activity-of-nf-%ce%bab-to-regulate-production-of-inflammatory-mediators-in-ra-fls/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clock-gene-bmal1-promotes-transcriptional-activity-of-nf-%ce%bab-to-regulate-production-of-inflammatory-mediators-in-ra-fls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology